Valerie G Sams1,2, Camille Blackledge3, Nadeeja Wijayatunga4, Patrick Barlow3, Matthew Mancini3, Gregory Mancini3, Naima Moustaid-Moussa3,4. 1. Department of Surgery, University of Tennessee Medical Center, Knoxville, TN, USA. Valerie.g.sams@gmail.com. 2. San Antonio Military Medical Center, 26 Campedn Circle, San Antonio, TX, 78209, USA. Valerie.g.sams@gmail.com. 3. Department of Surgery, University of Tennessee Medical Center, Knoxville, TN, USA. 4. Department of Nutritional Sciences, College of Human Sciences and The Obesity Research Cluster, Texas Tech University, Lubbock, TX, USA.
Abstract
BACKGROUND: Obese patients are predisposed to developing insulin resistance and associated metabolic diseases such as diabetes and cardiovascular disease. The objective of this study was to determine the effect of bariatric surgery on adipose-derived inflammatory cytokines (adipokines), which play a key role in insulin resistance and obesity. We hypothesized that there is a significant increase in serum and tissue anti-inflammatory adiponectin with a decrease in circulating pro-inflammatory TNF-α and MCP-1, leading to reduced inflammation post-bariatric surgery. METHODS: In this study, we investigated the effects of laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic gastric band on serum and tissue levels of adiponectin and serum levels of MCP-1 and TNF-α. Samples of serum and adipose tissue were collected at the time of surgery, 2 weeks and 6 months postoperatively. Adipokine levels were assayed by ELISA kits. RESULTS: A significant increase in adiponectin levels 2 weeks after surgery was observed in the subcutaneous adipose tissue in both groups combined. Serum adiponectin in LRYGB patients showed an increasing trend, while MCP-1 showed a decreasing trend post-surgery. There was no difference in TNF-α among the groups. The number of patients enrolled did not allow for statistical power to be reached. CONCLUSION: Our results show significant and rapid increases in subcutaneous adipose adiponectin as early as 2 weeks post-bariatric surgery demonstrating reduced inflammation and possibly reduced insulin resistance. Future studies are warranted in larger cohorts with additional measurements of insulin sensitivity and inflammation.
BACKGROUND: Obese patients are predisposed to developing insulin resistance and associated metabolic diseases such as diabetes and cardiovascular disease. The objective of this study was to determine the effect of bariatric surgery on adipose-derived inflammatory cytokines (adipokines), which play a key role in insulin resistance and obesity. We hypothesized that there is a significant increase in serum and tissue anti-inflammatory adiponectin with a decrease in circulating pro-inflammatory TNF-α and MCP-1, leading to reduced inflammation post-bariatric surgery. METHODS: In this study, we investigated the effects of laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic gastric band on serum and tissue levels of adiponectin and serum levels of MCP-1 and TNF-α. Samples of serum and adipose tissue were collected at the time of surgery, 2 weeks and 6 months postoperatively. Adipokine levels were assayed by ELISA kits. RESULTS: A significant increase in adiponectin levels 2 weeks after surgery was observed in the subcutaneous adipose tissue in both groups combined. Serum adiponectin in LRYGB patients showed an increasing trend, while MCP-1 showed a decreasing trend post-surgery. There was no difference in TNF-α among the groups. The number of patients enrolled did not allow for statistical power to be reached. CONCLUSION: Our results show significant and rapid increases in subcutaneous adipose adiponectin as early as 2 weeks post-bariatric surgery demonstrating reduced inflammation and possibly reduced insulin resistance. Future studies are warranted in larger cohorts with additional measurements of insulin sensitivity and inflammation.
Authors: Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel Journal: N Engl J Med Date: 2004-12-23 Impact factor: 91.245
Authors: Paul Poirier; Marc-André Cornier; Theodore Mazzone; Sasha Stiles; Susan Cummings; Samuel Klein; Peter A McCullough; Christine Ren Fielding; Barry A Franklin Journal: Circulation Date: 2011-03-14 Impact factor: 29.690
Authors: Derek K Hagman; Ilona Larson; Jessica N Kuzma; Gail Cromer; Karen Makar; Katya B Rubinow; Karen E Foster-Schubert; Brian van Yserloo; Peter S Billing; Robert W Landerholm; Matthew Crouthamel; David R Flum; David E Cummings; Mario Kratz Journal: Metabolism Date: 2017-02-02 Impact factor: 8.694
Authors: Risa M Wolf; Kimberley E Steele; Leigh A Peterson; Xiange Zeng; Andrew E Jaffe; Michael A Schweitzer; Thomas H Magnuson; G William Wong Journal: J Clin Endocrinol Metab Date: 2016-03-16 Impact factor: 5.958
Authors: T W McGlennon; J N Buchwald; Walter J Pories; Fang Yu; Arthur Roberts; Eric P Ahnfeldt; Rukmini Menon; Henry Buchwald Journal: Obes Surg Date: 2021-01-04 Impact factor: 4.129
Authors: Mario Kratz; Derek K Hagman; Jessica N Kuzma; Karen E Foster-Schubert; Chun P Chan; Skye Stewart; Brian van Yserloo; Emily O Westbrook; David E Arterburn; David R Flum; David E Cummings Journal: Obesity (Silver Spring) Date: 2016-05-26 Impact factor: 5.002